|
⚲
|
| Keyboard |
| SV Life Sciences Fund VI Strategic Partners LP
✚
|
|
|---|---|
| CIK # | 0001667605 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001667605] | |
| 4 | [0001667605] | |
| D | [0001667605] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tectonic Therapeutic Inc AVRO
Common Stock
|
2019-01-16 | Other | 778,663 | $0.00 | |
|
Tectonic Therapeutic Inc AVRO
Common Stock
|
2019-01-16 | Other | 26,660 | $0.00 | |
|
Tectonic Therapeutic Inc AVRO
Common Stock
|
2018-06-25 | Conversion | 75,591 | ||
|
Tectonic Therapeutic Inc AVRO
Common Stock
|
2018-06-25 | Conversion | 14,982 | ||
|
Tectonic Therapeutic Inc AVRO
Series B Preferred Stock · derivative
|
2018-06-25 | Conversion | 61,908 | $0.00 | |
|
Tectonic Therapeutic Inc AVRO
Common Stock
|
2018-06-25 | Conversion | 2,207,843 | ||
|
Tectonic Therapeutic Inc AVRO
Series A Preferred Stock · derivative
|
2018-06-25 | Conversion | 312,341 | $0.00 | |
|
Tectonic Therapeutic Inc AVRO
Series A Preferred Stock · derivative
|
2018-06-25 | Conversion | 9,122,809 | $0.00 | |
|
Tectonic Therapeutic Inc AVRO
Series B Preferred Stock · derivative
|
2018-06-25 | Conversion | 1,808,211 | $0.00 | |
|
Tectonic Therapeutic Inc AVRO
Common Stock
|
2018-06-25 | Conversion | 437,611 | ||
|
X4 Pharmaceuticals Inc ASNS
Common Stock
|
2017-11-20 | Conversion | 431,980 | ||
|
X4 Pharmaceuticals Inc ASNS
Common Stock
|
2017-11-20 | Conversion | 14,789 | ||
|
X4 Pharmaceuticals Inc ASNS
Common Stock
|
2017-11-20 | Buy | 483,448 | $10.00 | 4,834,480 |
|
X4 Pharmaceuticals Inc ASNS
Common Stock
|
2017-11-20 | Conversion | 111,955 | ||
|
X4 Pharmaceuticals Inc ASNS
Series D Convertible Preferred Stock · derivative
|
2017-11-20 | Conversion | 50,477 | $0.00 | |
|
X4 Pharmaceuticals Inc ASNS
Series D Convertible Preferred Stock · derivative
|
2017-11-20 | Conversion | 1,474,348 | $0.00 | |
|
X4 Pharmaceuticals Inc ASNS
Series D Convertible Preferred Stock · derivative
|
2017-11-20 | Conversion | 14,635 | $0.00 | |
|
X4 Pharmaceuticals Inc ASNS
Series D Convertible Preferred Stock · derivative
|
2017-11-20 | Conversion | 692,552 | $0.00 | |
|
X4 Pharmaceuticals Inc ASNS
Common Stock
|
2017-11-20 | Conversion | 19,128 | ||
|
X4 Pharmaceuticals Inc ASNS
Series C Convertible Preferred Stock · derivative
|
2017-11-20 | Conversion | 224,665 | $0.00 | |
| showing 20 of 36 most recent transactions | |||||